Zeta电位
PEG比率
生物相容性
表面改性
纳米颗粒
材料科学
体内
介孔材料
药剂学
化学
纳米技术
化学工程
生物物理学
药理学
医学
生物化学
有机化学
生物
工程类
财务
物理化学
生物技术
催化作用
经济
作者
Xinfang Li,Linzhao Wang,Lan She,Linhong Sun,Zhiqiang Ma,Min Chen,Pengwei Hu,Dan Wang,Feng Yang
标识
DOI:10.1016/j.colsurfb.2018.07.072
摘要
With large surface area and three-dimensional pore structure, mesoporous carbon nanoparticles (MCN) have attracted enormous interests as potential drug carriers. However, MCN immunotoxicity has not been clarified clearly up to now. Herein we reported the effect of MCN with and without PVP or DSPE mPEG2000 (PEG) modification on immune cells including dendritic cells (DCs), T lymphocytes and RAW264.7 macrophages in vitro. Furthermore, blood biochemical tests, alexin C3 assay and histological analysis were used to investigate the toxicity of MCN in vivo. The synthesized MCN with average particle size about 90 nm was naturally insoluble in water. Surface modification with PVP (MCN-PVP) or PEG (MCN-PEG) slightly increased the particle size and Zeta potential, and effectively improved the dispersion of mesoporous carbon. MCN, MCN-PVP and MCN-PEG promoted the differentiation and maturation of the DCs, while the levels of secreted TNF-α and IL-6 were significantly suppressed by MCN-PVP and MCN-PEG. These materials significantly induced apoptosis of T lymphocytes. The histopathologic results showed that there was no significant difference between nanoparticles with or without modification. Importantly, the materials deposition was observed in the lung, which could potentially inhibit lung metastasis. In conclusion, the ordered mesoporous carbon nanoparticles superficially modified by PVP or PEG perform well in immunological biocompatibility, and are likely to be a promising candidate as medicine carrier in pharmaceutics and clinic.
科研通智能强力驱动
Strongly Powered by AbleSci AI